Chapter 4 Market Dynamics
- Market Drivers
- Increasing Incidence of Cvd, Neurology and Ent Disorders
- Aging Population
- Increasing Healthcare Expenditures
- Focus on Non-Drug Therapies and Reducing Opioid Usage
- Technology Innovations and New Product Developments
- Market Restraints and Challenges
- High Cost of Neurostimulation Procedures/Devices and Lack of Trained Healthcare Professionals
- Inconsistent Reimbursement Policies
Chapter 5 Impact of Covid-19 Pandemic
- Introduction
- Impact on Neurostimulation Market
- Impact on Market for Ent Devices
Chapter 6 Global Market for Electroceuticals by Product
- Cardioverter Defibrillators and Cardiac Pacemakers
- Neurostimulation
- Spinal Cord Stimulation
- Deep Brain Stimulation
- Vagus Nerve Stimulation
- Sacral Nerve Stimulation
- Transcutaneous Electrical Nerve Stimulation
- Other Stimulators
- Hearing Aids and Implants
- Hearing Aid Devices
- Behind the Ear
- Completely in the Canal
- In the Ear
- Hearing Implants
- Cochlear Implants
- Bone Anchored Hearing Implants
- Middle Ear Implants
Chapter 7 Global Market for Electroceuticals by End-user
- Hospitals and Clinics
- Homecare and Others
Chapter 8 Global Market for Electroceuticals by Region
- North America
- U.S.
- Europe
- Asia-Pacific
- Japan
- China
- India
- Rest of the World
Chapter 10 Competitive Landscape
- Leading Companies in the Market for Neurostimulation Products
- Spinal Cord Stimulation Devices
- Deep Brain Stimulation Devices
- Market for Hearing Aids and Implants by Company
- Key Developments
Chapter 11 Company Profiles
- Abbott Laboratories
- Axonics Modulation Technologies Inc.
- Bioventus LLC
- Biotronik Se & Co. Kg
- Boston Scientific Corp.
- Cochlear Americas
- Cook Medical
- Edwards Lifesciences Corp.
- GlaxoSmithKline plc
- Lepu Medical Technology (Beijing) Co. Ltd.
- Livanova plc
- Medico S.P.A.
- Medtronic plc
- Microport Scientific Corp.
- Stryker Corp.
- Zoll Medical Corp.
List of Tables
Summary Table A: Global Market for Electroceuticals, by Product, Through 2027
Table 1: Regulatory Approval: U.S. vs. Europe
Table 2: U.S. FDA Product Classification: Defibrillators
Table 3: U.S. FDA Pacemaker Product Classification
Table 4: U.S. FDA Neurostimulator Product Classification, 2019
Table 5: U.S. FDA Cochlear Implant Product Classification
Table 6: Global Incidence of All Stroke Types, 2019
Table 7: Global Prevalence of Congestive Heart Failure and Stroke, Through 2030
Table 8: Number of Disability-adjusted Life Years (DALYs)for Neurological Disorders and Share of Global DALYs Projected for 2005 and 2030
Table 9: Deaths Attributable to Neurological Disorders, 2005 and 2030
Table 10: World Population, Age 60 and Older, 2000-2050
Table 11: Global Market for Electroceuticals, by Product, 2020-2027
Table 12: Global Market for Cardioverter Defibrillators and Cardiac Pacemakers, by Region, Through 2027
Table 13: Global Market for Spinal Cord Stimulators, by Region, Through 2027
Table 14: Global Market for Deep Brain Stimulators, by Region, Through 2027
Table 15: Global Market for Vagus Nerve Stimulators, by Region, Through 2027
Table 16: Global Market for Other Stimulators, by Region, Through 2027
Table 17: Global Market for Hearing Aids and Implants, by Region, Through 2027
Table 18: Global Market for Electroceuticals, by End User, 2020-2027
Table 19: Global Market for Hospitals and Clinics, by Region, Through 2027
Table 20: Hospitals with Notable Services
Table 21: Global Market for Homecare and Others, by Region, Through 2027
Table 22: Global Market for Electroceuticals, by Region, 2020-2027
Table 23: North American Market for Electroceuticals, by Country, Through 2027
Table 24: Funding by Federal Government for Treatment of Chronic Diseases
Table 25: European Market for Electroceuticals, by Country, Through 2027
Table 26: Asia-Pacific Market for Electroceuticals, by Country, Through 2027
Table 27: China’s Medical Device Regulations
Table 28: Out-of-Pocket Health Expenditures in Argentina, 2015-2019
Table 29: Analysis of Patents Related to Electroceuticals
Table 30: Number of Patents Related to Neurostimulation, by Patent Holder, January 2020 to May 2022
Table 31: Number of Patents Related to Cardiac Stimulation, by Patent Holder, January 2020 to May 2022
Table 32: Global Market Shares of Spinal Cord Stimulation Devices, by Company, 2020
Table 33: Global Market Shares of Deep Brain Stimulation Devices, by Company, 2020
Table 34: Abbott: Product Portfolio
Table 35: Bioness: Product Information
Table 36: Product Portfolio
Table 37: Medico S.p.A.: Main Products
Table 38: Medico S.p.A.: Recent Developments
Table 39: Medtronic: Product Portfolio
Table 40: MicroPort Scientific Corp.: Product Portfolio
Table 41: Zoll Medical Corp.: Product Portfolio
Table 42: Acronyms Used in This Report
List of Figures
Summary Figure A: Global Market for Electroceuticals, 2020-2027
Figure 1: Global Deaths from CVD, 2015 and 2030
Figure 2: Global Prevalence of Congestive Heart Failure and Stroke, 2004-2030
Figure 3: Global Market for Electroceuticals, by Product, 2020-2027
Figure 4: Pacemakers
Figure 5: Global Market for Electroceuticals, by End User, 2020-2027
Figure 6: Number of Hospitals in the U.S., by Type, 2020
Figure 7: Healthcare Expenditures in the U.S., 2015 and 2025
Figure 8: Trends in Healthcare Spending, by Institution, 2015-2040
Figure 9: North American Market Shares of Electroceuticals, by Country, 2021
Figure 10: European Market Shares of Electroceuticals, by Country, 2021
Figure 11: Asia-Pacific Market Shares of Electroceuticals, by Country, 2021
Figure 12: Out-of-Pocket Health Expenditures in Argentina, 2015-2019
Figure 13: Percentage of Patents on Hearing Aids and Implants, by Country, January 2020 to May 2022
Figure 14: Percentage of Patents on Hearing Aids and Implants, by Patent Holder, January 2020 to May 2022
Figure 15: Percentage of Patents Related to Neurostimulation, by Country, January 2020 to May 2022
Figure 16: Global Market Shares of Spinal Cord Stimulation Devices, by Company, 2020
Figure 17: Global Market Shares of Deep Brain Stimulation Devices, by Company, 2020
Figure 18: Global Market Shares of Hearing Aids and Implants, by Company, 2020
Figure 19: Global Market Shares of Hearing Aids and Implants, by Company, 2020
Figure 20: Abbott: Annual Revenue, 2018-2021
Figure 21: Abbott: Vascular Business Annual Revenue, 2018-2021
Figure 22: Abbott: Revenue Share, by Country, 2021
Figure 23: Boston Scientific: Annual Revenue, 2018-2021
Figure 24: Boston Scientific: Revenue Share, by Business, 2021
Figure 25: Boston Scientific: Revenue Share, by Region, 2021
Figure 26: GlaxoSmithKline plc: Annual Revenue, 2018-2020
Figure 27: GlaxoSmithKline plc: Revenue Share, by Business Segment, 2020
Figure 28: Medtronic: Annual Revenue, 2018-2021
Figure 29: Medtronic Coronary & Peripheral Vascular Segment: Annual Revenue, 2019-2021
Figure 30: Medtronic: Revenue Share, by Region, 2021
